Details of the Drug Combination

General Information of Drug Combination (ID: DC981UX)

Drug Combination Name
Trientine Hydrochloride Trientine Hydrochloride
Indication
Disease Entry Status REF
Wilson Disease Phase 3 [1]
Component Drugs Trientine Hydrochloride   DM0KCV1 Trientine Hydrochloride   DM0KCV1
Small molecular drug Small molecular drug
2D MOL 2D MOL
3D MOL is unavailable 3D MOL is unavailable

References

1 ClinicalTrials.gov (NCT03539952) Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015